abrdn plc Cuts Stock Holdings in Colgate-Palmolive (NYSE:CL)

abrdn plc decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 7.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 328,041 shares of the company’s stock after selling 26,220 shares during the period. abrdn plc’s holdings in Colgate-Palmolive were worth $29,645,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CL. Trust Point Inc. boosted its holdings in shares of Colgate-Palmolive by 2.1% in the 4th quarter. Trust Point Inc. now owns 20,327 shares of the company’s stock valued at $1,848,000 after buying an additional 417 shares in the last quarter. Childress Capital Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 8.3% in the 4th quarter. Childress Capital Advisors LLC now owns 2,428 shares of the company’s stock valued at $221,000 after buying an additional 187 shares in the last quarter. Optas LLC boosted its holdings in shares of Colgate-Palmolive by 3.1% in the 4th quarter. Optas LLC now owns 14,458 shares of the company’s stock valued at $1,314,000 after buying an additional 431 shares in the last quarter. Catalina Capital Group LLC boosted its holdings in shares of Colgate-Palmolive by 15.3% in the 4th quarter. Catalina Capital Group LLC now owns 2,990 shares of the company’s stock valued at $272,000 after buying an additional 397 shares in the last quarter. Finally, S.A. Mason LLC boosted its holdings in shares of Colgate-Palmolive by 6.3% in the 4th quarter. S.A. Mason LLC now owns 3,435 shares of the company’s stock valued at $312,000 after buying an additional 204 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $86.66 on Thursday. The firm has a market cap of $70.80 billion, a PE ratio of 24.62, a PEG ratio of 3.61 and a beta of 0.44. The firm has a fifty day moving average of $90.98 and a 200 day moving average of $96.99. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm posted $0.87 earnings per share. As a group, research analysts predict that Colgate-Palmolive will post 3.74 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CL. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.